Literature DB >> 28221276

A Comparison of Self-reported Medication Adherence to Concordance Between Part D Claims and Medication Possession.

Samuel T Savitz1, Sally C Stearns, Lei Zhou, Emily Thudium, Khalid A Alburikan, Richard Tran, Jo E Rodgers.   

Abstract

OBJECTIVE: Medicare Part D claims indicate medication purchased, but people who are not fully adherent may extend prescription use beyond the interval prescribed. This study assessed concordance between Part D claims and medication possession at a study visit in relation to self-reported medication adherence.
MATERIALS AND METHODS: We matched Part D claims for 6 common medications to medications brought to a study visit in 2011-2013 for the Atherosclerosis Risk in Communities study. The combined data consisted of 3027 medication events (claims, medications possessed, or both) for 2099 Atherosclerosis Risk in Communities study participants. Multinomial logistic regression estimated the association of concordance (visit only, Part D only, or both) with self-reported medication adherence while controlling for sociodemographic characteristics, veteran status, and availability under Generic Drug Discount Programs.
RESULTS: Relative to participants with high adherence, medication events for participants with low adherence were approximately 25 percentage points less likely to match and more likely to be visit only (P<0.001). The results were similar but smaller in magnitude (approximately 2-3 percentage points) for participants with medium adherence. Compared with females, medication events for male veterans were approximately 11 percentage points less likely to match and more likely to be visit only. Events for medications available through Generic Drug Discount Programs were 3 percentage points more likely to be visit only.
CONCLUSIONS: Part D claims were substantially less likely to be concordant with medications possessed at study visit for participants with low self-reported adherence. This result supports the construction of adherence proxies such as proportion days covered using Part D claims.

Entities:  

Mesh:

Year:  2017        PMID: 28221276      PMCID: PMC5391286          DOI: 10.1097/MLR.0000000000000701

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  11 in total

1.  Implications of the accuracy of MEPS prescription drug data for health services research.

Authors:  Steven C Hill; Samuel H Zuvekas; Marc W Zodet
Journal:  Inquiry       Date:  2011       Impact factor: 1.730

2.  Access to and use of $4 generic programs in Medicare.

Authors:  Yuting Zhang; Walid F Gellad; Lei Zhou; Yi-Jen Lin; Judith R Lave
Journal:  J Gen Intern Med       Date:  2012-02-07       Impact factor: 5.128

3.  Medicare Part D enrollees' use of out-of-plan discounted generic drugs.

Authors:  Bruce Stuart; F Ellen Loh; Ellen F Loh
Journal:  J Am Geriatr Soc       Date:  2012-02       Impact factor: 5.562

Review 4.  Adherence to medication.

Authors:  Lars Osterberg; Terrence Blaschke
Journal:  N Engl J Med       Date:  2005-08-04       Impact factor: 91.245

5.  Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures.

Authors:  Lisa M Hess; Marsha A Raebel; Douglas A Conner; Daniel C Malone
Journal:  Ann Pharmacother       Date:  2006 Jul-Aug       Impact factor: 3.154

6.  Out-of-plan medication in Medicare Part D.

Authors:  Pamela N Roberto; Bruce Stuart
Journal:  Am J Manag Care       Date:  2014-09       Impact factor: 2.229

7.  Response letter to Jonathan Harding.

Authors:  Bruce Stuart; F Ellen Loh
Journal:  J Am Geriatr Soc       Date:  2013-02       Impact factor: 5.562

8.  Assessing Medicare Part D claim completeness using medication self-reports: the role of veteran status and Generic Drug Discount Programs.

Authors:  Lei Zhou; Sally C Stearns; Emily M Thudium; Khalid A Alburikan; Jo E Rodgers
Journal:  Med Care       Date:  2015-05       Impact factor: 2.983

9.  Military combat and risk of coronary heart disease and ischemic stroke in aging men: The Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Anna M Johnson; Kathryn M Rose; Glen H Elder; Lloyd E Chambless; Jay S Kaufman; Gerardo Heiss
Journal:  Ann Epidemiol       Date:  2010-02       Impact factor: 3.797

10.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.

Authors: 
Journal:  Am J Epidemiol       Date:  1989-04       Impact factor: 4.897

View more
  5 in total

1.  Predictors of Medication Adherence in the Elderly: The Role of Mental Health.

Authors:  Jo E Rodgers; Emily M Thudium; Hadi Beyhaghi; Carla A Sueta; Khalid A Alburikan; Anna M Kucharska-Newton; Patricia P Chang; Sally C Stearns
Journal:  Med Care Res Rev       Date:  2017-03-23       Impact factor: 3.929

2.  Adherence to colorectal cancer screening measured as the proportion of time covered.

Authors:  Caitlin C Murphy; Bianca M Sigel; Edward Yang; Celette Sugg Skinner; Ethan A Halm; Samir Gupta; Joanne M Sanders; Katharine McCallister; Amit G Singal
Journal:  Gastrointest Endosc       Date:  2018-02-23       Impact factor: 9.427

3.  Opioid Prescriptions by Pain Medicine Physicians in the Medicare Part D Program: A Cross-Sectional Study.

Authors:  Vasudha Goel; Benedict Moran; Alexander M Kaizer; Eellan Sivanesan; Amol M Patwardhan; Mohab Ibrahim; Jacob C DeWeerth; Clarence Shannon; Hariharan Shankar
Journal:  Anesth Analg       Date:  2021-06-01       Impact factor: 6.627

4.  Quantifying cumulative anticholinergic and sedative drug load among US Medicare Beneficiaries.

Authors:  Shahar Shmuel; Virginia Pate; Marc J Pepin; Janine C Bailey; Laura C Hanson; Til Stürmer; Rebecca B Naumann; Yvonne M Golightly; Danijela Gnjidic; Jennifer L Lund
Journal:  Pharmacoepidemiol Drug Saf       Date:  2020-10-15       Impact factor: 2.890

5.  Can caregivers report their care recipients' post-stroke hospitalizations and outpatient visits accurately? Findings of an Asian prospective stroke cohort.

Authors:  Shilpa Tyagi; Gerald Choon-Huat Koh; Nan Luo; Kelvin Bryan Tan; Helen Hoenig; David B Matchar; Joanne Yoong; Eric A Finkelstein; Kim En Lee; N Venketasubramanian; Edward Menon; Kin Ming Chan; Deidre Anne De Silva; Philip Yap; Boon Yeow Tan; Effie Chew; Sherry H Young; Yee Sien Ng; Tian Ming Tu; Yan Hoon Ang; Keng He Kong; Rajinder Singh; Reshma A Merchant; Hui Meng Chang; Tseng Tsai Yeo; Chou Ning; Angela Cheong; Yu Li Ng; Chuen Seng Tan
Journal:  BMC Health Serv Res       Date:  2018-10-25       Impact factor: 2.655

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.